City and state of New York quarrel over NYC Health + Hospitals’ finances

John Gregory | | Health Exec | Economics

Cuts to Medicaid Disproportionate Share Hospital (DSH) payments, a delay in state payments and lack of help from the city are all being blamed for the financial predicament of NYC Health + Hospitals, the largest public hospital system in the U.S.

The delayed DSH cuts kicked in on Oct. 1, with New York hospitals estimated to lose between $329 million (according to CMS) and $1.1 billion (according to the state). NYC Health + Hospitals already had a projected budget deficit of $1.1 billion for 2018. Its outgoing CEO, Stan Brezenoff, accused the state of exacerbating those financial problems, claiming in a letter obtained by POLITICO its withholding $380 million in DSH funds from the system.

New York Gov. Andrew Cuomo disputed those claims. His budget director told the New York Times there’s no set schedule to release federal DSH funds to the system, and suggested the city of New York should use financial reserves to fill the system’s budget gap.

“The first source of financial assistance for these hospitals must be their associated local governments,” he said.

Read more at the link below:

With Federal Cuts to Hospitals, Cuomo Suggests New York City Step Up

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Related Content

Bipartisan group of 233 House members call for Medicare reform
Wartime powers enacted to address nationwide IV fluid shortage
Cardiologist compensation still rising, especially in invasive and interventional cardiology
Baxter begins importing IV supplies as 86% of providers report shortages
CMS proposes rule to combat gray market health insurance scams
Private equity firm buys controlling stake in Surescripts

Around the web

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Cardiovascular Business
Cardiology groups cheer new bill that would improve access to Medicare claims data

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup